Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6530 | 1405 | 27.0 | 44% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TORASEMIDE | Author keyword | 67 | 62% | 5% | 69 |
2 | TORSEMIDE | Author keyword | 18 | 61% | 1% | 19 |
3 | FUROSEMIDE | Author keyword | 13 | 10% | 8% | 118 |
4 | LOOP DIURETICS | Author keyword | 9 | 21% | 3% | 39 |
5 | METOLAZONE | Author keyword | 6 | 48% | 1% | 10 |
6 | DIURETIC RESISTANCE | Author keyword | 6 | 33% | 1% | 14 |
7 | XIPAMIDE | Author keyword | 4 | 47% | 0% | 7 |
8 | BEMETIZIDE | Author keyword | 3 | 100% | 0% | 3 |
9 | SEGMENTAL NEPHRON BLOCKADE | Author keyword | 3 | 100% | 0% | 3 |
10 | FRUSEMIDE | Author keyword | 3 | 14% | 1% | 19 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TORASEMIDE | 67 | 62% | 5% | 69 | Search TORASEMIDE | Search TORASEMIDE |
2 | TORSEMIDE | 18 | 61% | 1% | 19 | Search TORSEMIDE | Search TORSEMIDE |
3 | FUROSEMIDE | 13 | 10% | 8% | 118 | Search FUROSEMIDE | Search FUROSEMIDE |
4 | LOOP DIURETICS | 9 | 21% | 3% | 39 | Search LOOP+DIURETICS | Search LOOP+DIURETICS |
5 | METOLAZONE | 6 | 48% | 1% | 10 | Search METOLAZONE | Search METOLAZONE |
6 | DIURETIC RESISTANCE | 6 | 33% | 1% | 14 | Search DIURETIC+RESISTANCE | Search DIURETIC+RESISTANCE |
7 | XIPAMIDE | 4 | 47% | 0% | 7 | Search XIPAMIDE | Search XIPAMIDE |
8 | BEMETIZIDE | 3 | 100% | 0% | 3 | Search BEMETIZIDE | Search BEMETIZIDE |
9 | SEGMENTAL NEPHRON BLOCKADE | 3 | 100% | 0% | 3 | Search SEGMENTAL+NEPHRON+BLOCKADE | Search SEGMENTAL+NEPHRON+BLOCKADE |
10 | FRUSEMIDE | 3 | 14% | 1% | 19 | Search FRUSEMIDE | Search FRUSEMIDE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TORASEMIDE | 55 | 62% | 4% | 56 |
2 | TORSEMIDE | 47 | 79% | 2% | 30 |
3 | LOOP DIURETICS | 31 | 32% | 6% | 83 |
4 | FUROSEMIDE | 23 | 12% | 12% | 172 |
5 | DIURETIC EFFICIENCY | 18 | 89% | 1% | 8 |
6 | FUROSEMIDE KINETICS | 17 | 100% | 1% | 8 |
7 | FRUSEMIDE | 16 | 24% | 4% | 58 |
8 | METOLAZONE | 10 | 52% | 1% | 13 |
9 | NATRIURETIC EFFECT ADDITION | 9 | 83% | 0% | 5 |
10 | PERMUTATION TRIAL TESTS | 9 | 83% | 0% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Diuretic therapy | 1998 | 230 | 62 | 76% |
TORASEMIDE - AN UPDATE OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY | 1995 | 59 | 53 | 81% |
Loop diuretics: from the Na-K-2Cl transporter to clinical use | 2003 | 46 | 84 | 67% |
Update in Diuretic Therapy: Clinical Pharmacology | 2011 | 5 | 70 | 73% |
TORASEMIDE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL | 1991 | 59 | 40 | 98% |
CONTINUOUS-INFUSION OF LOOP DIURETICS IN THE CRITICALLY ILL - A REVIEW OF THE LITERATURE | 1994 | 47 | 18 | 89% |
Combination of Loop Diuretics With Thiazide-Type Diuretics in Heart Failure | 2010 | 56 | 40 | 48% |
Pharmacology of diuretics | 2000 | 39 | 54 | 44% |
Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: An observational study and review of the literature | 2005 | 21 | 16 | 63% |
FUROSEMIDE PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTH AND DISEASE - AN UPDATE | 1989 | 89 | 74 | 89% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DRUG CIM | 1 | 38% | 0.2% | 3 |
2 | CLIN FUNCT DIAGNOST | 1 | 50% | 0.1% | 1 |
3 | DEV PHARMACOL PERINATAL UNIT | 1 | 50% | 0.1% | 1 |
4 | GRP EVALUAC BIOL SUSTANCIAS PROMISORIAS | 1 | 50% | 0.1% | 1 |
5 | INNERE MED NEPHROL 3 | 1 | 50% | 0.1% | 1 |
6 | KLIN IMMUNOL TRANSPLANTOL CHOROB WEWNETRZNYCH | 1 | 50% | 0.1% | 1 |
7 | MECH CIRCULATORY SUPPORT HEART TRANSPLANTAT PRO | 1 | 50% | 0.1% | 1 |
8 | MED SURG NEPHROL | 1 | 50% | 0.1% | 1 |
9 | RENAL SECT 111FU | 1 | 50% | 0.1% | 1 |
10 | SECT NEPHROL 111C | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000196704 | AMILORIDE DETERMINATION//FUROSEMIDE DETERMINATION//CHERRY SYRUP |
2 | 0.0000181238 | INHALED FUROSEMIDE//ULTRASONICALLY NEBULIZED DISTILLED WATER INHALATION CHALLENGE//FRUSEMIDE |
3 | 0.0000136290 | ICI 206 970//POTASSIUM BLOOD//EUKALEMIC |
4 | 0.0000124863 | INDAPAMIDE//CLIN NUTR METAB DIS//PHARMACOL PHYSIOPATHOL CARDIOVASC |
5 | 0.0000124266 | NEPHROTIC EDEMA//CYCLOPHILIN LIKE PROTEIN//UNIT CARDIOVASC METAB PREVENT |
6 | 0.0000107455 | ASAN FDN//DA 125//MED DIAGNOST PATHOL |
7 | 0.0000091479 | M17055//1 2 BENZISOXAZOLE//URICOSURIC ACTIVITY |
8 | 0.0000082868 | NESIRITIDE//ACUTE HEART FAILURE//CARDIORENAL SYNDROME |
9 | 0.0000077448 | SNGFR//LITHIUM CLEARANCE//GLOMERULO TUBULAR BALANCE |
10 | 0.0000061638 | CAS 396 01 0//CRYSTALLURIA//CALCULI ANALYSIS |